On the latest Talk Ya Book, Chris Judd welcomes back Andrew Chapman from Merchant Funds Management. Andrew talks us through bio-tech company Inoviq (ASX:IIQ), whose goal is to develop and commercialise a portfolio of diagnostic and exosome-based products for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases.

Merchant Funds Management specialise in small and micro-cap companies listed on the ASX.

Proudly presented by Honan (www.honan.com.au).

On the latest Talk Ya Book, Chris Judd welcomes back Andrew Chapman from Merchant Funds Management. Andrew talks us through bio-tech company Inoviq (ASX:IIQ), whose goal is to develop and commercialise a portfolio of diagnostic and exosome-based products for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases.
Merchant Funds Management specialise in small and micro-cap companies listed on the ASX.
Proudly presented by Honan (www.honan.com.au).

Talk Ya Book shines a light on the investment processes used by Australia's best investors as they talk through their highest conviction investment idea. 

Talk Ya Book shines a light on the investment processes used by Australia's best investors as they talk through their highest conviction investment idea.&nbsp;

Advertisement